bf/NYSE:BIO_icon.jpeg

NYSE:BIO.B

Bio-Rad Laboratories, Inc.

  • Stock

USD

Last Close

281.80

14/06 20:00

Market Cap

9.53B

Beta: -

Volume Today

199.01K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
2.13B
-
2.18B
1.99%
2.02B
7.15%
2.07B
2.41%
2.16B
4.45%
2.29B
6.02%
2.31B
0.94%
2.55B
10.12%
2.92B
14.81%
2.80B
4.12%
2.67B
4.67%
cost of revenue
954.22M
-
996.53M
4.43%
897.77M
9.91%
930.09M
3.60%
972.75M
4.59%
1.07B
9.56%
1.05B
1.04%
1.11B
5.04%
1.28B
15.71%
1.23B
3.66%
1.24B
0.40%
gross profit
1.18B
-
1.18B
0.00%
1.12B
4.82%
1.14B
1.46%
1.19B
4.33%
1.22B
3.11%
1.26B
2.67%
1.44B
14.39%
1.64B
14.11%
1.57B
4.47%
1.43B
8.68%
selling and marketing expenses
-1.49M
-
general and administrative expenses
798.07M
-
808.20M
1.27%
761.99M
5.72%
816.72M
7.18%
808.94M
0.95%
834.78M
3.19%
selling general and administrative expenses
798.07M
-
808.20M
1.27%
761.99M
5.72%
816.72M
7.18%
808.94M
0.95%
833.29M
3.01%
824.63M
1.04%
800.27M
2.95%
879.57M
9.91%
827.83M
5.88%
820.62M
0.87%
research and development expenses
210.95M
-
220.33M
4.45%
192.97M
12.42%
205.86M
6.68%
250.30M
21.59%
199.20M
20.42%
202.71M
1.76%
226.60M
11.78%
271.66M
19.88%
256.89M
5.44%
226.93M
11.66%
other expenses
12.77M
-
13.01M
1.90%
11.08M
14.83%
14.85M
34.03%
12.20M
17.87%
36.59M
200.02%
26.09M
28.69%
24.49M
6.15%
26.77M
9.34%
44.57M
66.48%
2.30M
94.84%
cost and expenses
1.96B
-
2.03B
3.15%
1.85B
8.51%
1.95B
5.39%
2.03B
4.06%
2.10B
3.26%
2.08B
0.77%
2.13B
2.53%
2.43B
13.98%
2.32B
4.66%
2.29B
1.39%
operating expenses
1.01B
-
1.03B
1.93%
954.96M
7.15%
1.02B
7.08%
1.06B
3.58%
1.03B
2.53%
1.03B
0.50%
1.03B
0.05%
1.15B
12.11%
1.08B
5.78%
1.05B
3.43%
interest expense
61.27M
-
22.13M
63.88%
21.69M
1.98%
21.94M
1.15%
21.91M
0.13%
23.96M
9.35%
23.42M
2.28%
21.86M
6.64%
1.55M
92.91%
38.11M
2,357.38%
49.44M
29.71%
ebitda
329.38M
-
312.88M
5.01%
309.64M
1.04%
273.25M
11.75%
289.04M
5.78%
366.55M
26.82%
389.99M
6.39%
573.57M
47.07%
650.01M
13.33%
664.49M
2.23%
576.20M
13.29%
operating income
169.46M
-
149.98M
11.49%
166.71M
11.15%
53.19M
68.09%
116.65M
119.29%
-108.64M
193.13%
229.66M
311.39%
410.96M
78.94%
489.43M
19.10%
482.62M
1.39%
383.80M
20.48%
depreciation and amortization
147.16M
-
149.89M
1.86%
131.85M
12.04%
142.90M
8.38%
148.68M
4.05%
138.09M
7.13%
160.33M
16.11%
162.62M
1.42%
160.58M
1.25%
181.87M
13.26%
192.40M
5.79%
total other income expenses net
4.20M
-
3.70M
11.81%
831K
77.56%
-52.00M
6,357.16%
-8.44M
83.77%
339.45M
4,123.34%
2.03B
498.45%
4.50B
121.36%
4.95B
10.05%
-5.19B
204.81%
-1.23B
76.21%
income before tax
112.39M
-
131.56M
17.06%
145.85M
10.86%
41.56M
71.50%
97.81M
135.33%
507.36M
418.75%
2.26B
345.66%
4.91B
117.05%
5.44B
10.81%
-4.70B
186.51%
-850.10M
81.93%
income tax expense
34.57M
-
42.71M
23.54%
32.75M
23.31%
13.44M
58.98%
-16.93M
226.05%
146.36M
964.26%
502.41M
243.26%
1.10B
119.22%
1.19B
8.25%
-1.08B
190.31%
-212.78M
80.24%
net income
77.79M
-
88.84M
14.21%
113.09M
27.29%
28.13M
75.13%
114.74M
307.96%
361.00M
214.62%
1.76B
387.17%
3.81B
116.88%
4.25B
11.54%
-3.63B
185.27%
-637.32M
82.43%
weighted average shs out
28.59M
-
28.88M
1.01%
29.19M
1.07%
29.44M
0.87%
29.66M
0.73%
29.84M
0.61%
29.84M
0.02%
29.77M
0.25%
29.83M
0.21%
29.79M
0.15%
29.21M
1.93%
weighted average shs out dil
28.91M
-
29.13M
0.79%
29.41M
0.95%
29.65M
0.81%
30.03M
1.31%
30.23M
0.65%
30.18M
0.15%
30.16M
0.08%
30.21M
0.16%
29.79M
1.40%
29.21M
1.93%
eps
2.72
-
3.08
13.24%
3.74
21.43%
0.88
76.47%
4.12
368.18%
12.10
193.69%
58.93
387.02%
127.86
116.97%
142.61
11.54%
-121.79
185.40%
-21.82
82.08%
epsdiluted
2.69
-
3.05
13.38%
3.71
21.64%
0.88
76.28%
4.07
362.50%
11.94
193.37%
58.27
388.02%
126.20
116.58%
140.83
11.59%
-121.79
186.48%
-21.82
82.08%

All numbers in USD (except ratios and percentages)